CRs with Blinatumomab in Children with Refractory/Relapsed BCP-ALL (CME/CE)

(MedPage Today) -- 'Toxicities not nontoxic, but generally quite manageable with good supportive care'
via CRs with Blinatumomab in Children with Refractory/Relapsed BCP-ALL (CME/CE)
by